G1/S DNA Damage Checkpoints |
11 |
2 |
2 |
5.40E-04 |
11 |
2 |
1 |
4.64E-02 |
Stabilization of p53 |
5 |
2 |
2 |
5.78E-04 |
5 |
2 |
1 |
5.08E-02 |
p53-Dependent G1 DNA Damage Response |
7 |
2 |
2 |
5.78E-04 |
7 |
2 |
1 |
5.08E-02 |
p53-Dependent G1/S DNA damage checkpoint |
7 |
2 |
2 |
5.78E-04 |
7 |
2 |
1 |
5.08E-02 |
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members |
9 |
3 |
2 |
1.70E-03 |
|
|
|
|
p53 signaling pathway |
14 |
11 |
3 |
1.98E-03 |
|
|
|
|
atm signaling pathway |
17 |
13 |
3 |
3.31E-03 |
17 |
13 |
2 |
4.28E-02 |
Class I PI3K signaling events |
456 |
181 |
12 |
4.91E-03 |
456 |
181 |
10 |
1.43E-02 |
Aurora A signaling |
117 |
43 |
5 |
5.49E-03 |
|
|
|
|
hypoxia and p53 in the cardiovascular system |
27 |
16 |
3 |
6.13E-03 |
|
|
|
|
tumor suppressor arf inhibits ribosomal biogenesis |
27 |
16 |
3 |
6.13E-03 |
|
|
|
|
inhibition of cellular proliferation by gleevec |
21 |
17 |
3 |
6.67E-03 |
21 |
17 |
2 |
5.93E-02 |
nfkb activation by nontypeable hemophilus influenzae |
29 |
17 |
3 |
6.67E-03 |
29 |
17 |
2 |
5.93E-02 |
TRAIL signaling pathway |
641 |
246 |
15 |
7.54E-03 |
641 |
246 |
15 |
3.24E-03 |
IL2 signaling events mediated by PI3K |
110 |
33 |
5 |
7.73E-03 |
|
|
|
|
Activation of BH3-only proteins |
13 |
6 |
2 |
8.12E-03 |
|
|
|
|
cell cycle: g2/m checkpoint |
24 |
19 |
3 |
1.01E-02 |
24 |
19 |
2 |
8.48E-02 |
Signaling events mediated by HDAC Class III |
44 |
21 |
3 |
1.22E-02 |
44 |
21 |
2 |
8.62E-02 |
repression of pain sensation by the transcriptional regulator dream |
15 |
8 |
2 |
1.38E-02 |
|
|
|
|
mapkinase signaling pathway |
41 |
39 |
4 |
1.40E-02 |
41 |
39 |
3 |
7.84E-02 |
rna polymerase iii transcription |
10 |
8 |
2 |
1.47E-02 |
|
|
|
|
Signaling events regulated by Ret tyrosine kinase |
131 |
40 |
4 |
1.61E-02 |
|
|
|
|
Signaling by Aurora kinases |
162 |
59 |
5 |
1.76E-02 |
|
|
|
|
IL2-mediated signaling events |
184 |
64 |
6 |
1.87E-02 |
184 |
64 |
5 |
6.96E-02 |
Role of Calcineurin-dependent NFAT signaling in lymphocytes |
133 |
64 |
5 |
1.88E-02 |
|
|
|
|
oxidative stress induced gene expression via nrf2 |
16 |
10 |
2 |
2.15E-02 |
|
|
|
|
G(s)-alpha mediated events in glucagon signalling |
5 |
1 |
1 |
2.33E-02 |
|
|
|
|
Activation of PUMA and translocation to mitochondria |
1 |
1 |
1 |
2.41E-02 |
|
|
|
|
Activation of NOXA and translocation to mitochondria |
1 |
1 |
1 |
2.41E-02 |
|
|
|
|
G2/M DNA damage checkpoint |
7 |
1 |
1 |
2.41E-02 |
|
|
|
|
Intrinsic Pathway for Apoptosis |
32 |
12 |
2 |
3.05E-02 |
|
|
|
|
agrin in postsynaptic differentiation |
23 |
13 |
2 |
3.55E-02 |
|
|
|
|
cadmium induces dna synthesis and proliferation in macrophages |
37 |
13 |
2 |
3.55E-02 |
|
|
|
|
Plasma membrane estrogen receptor signaling |
547 |
217 |
11 |
3.66E-02 |
547 |
217 |
9 |
8.14E-02 |
il-2 receptor beta chain in t cell activation |
42 |
31 |
3 |
3.77E-02 |
|
|
|
|
hypoxia-inducible factor in the cardivascular system |
26 |
14 |
2 |
4.08E-02 |
|
|
|
|
BMP receptor signaling |
329 |
163 |
9 |
4.33E-02 |
329 |
163 |
8 |
4.54E-02 |
Class I PI3K signaling events mediated by Akt |
160 |
55 |
4 |
4.35E-02 |
|
|
|
|
rho-selective guanine exchange factor akap13 mediates stress fiber formation |
11 |
2 |
1 |
4.60E-02 |
11 |
2 |
1 |
4.64E-02 |
FasL/CD95L signaling |
6 |
2 |
1 |
4.75E-02 |
|
|
|
|
alk in cardiac myocytes |
20 |
15 |
2 |
4.93E-02 |
20 |
15 |
3 |
6.12E-03 |
role of mef2d in t-cell apoptosis |
31 |
15 |
2 |
5.22E-02 |
31 |
15 |
4 |
4.38E-04 |
TNF receptor signaling pathway |
495 |
213 |
11 |
7.61E-02 |
495 |
213 |
11 |
3.77E-02 |
integrin signaling pathway |
28 |
21 |
2 |
9.19E-02 |
28 |
21 |
3 |
1.42E-02 |
FAS signaling pathway (CD95) |
|
|
|
|
63 |
26 |
5 |
2.99E-03 |
endocytotic role of ndk phosphins and dynamin |
|
|
|
|
22 |
6 |
2 |
7.76E-03 |
BCR signaling pathway |
|
|
|
|
94 |
52 |
5 |
8.63E-03 |
Integrins in angiogenesis |
|
|
|
|
107 |
38 |
4 |
1.18E-02 |
Alkaloid biosynthesis II |
|
|
|
|
45 |
21 |
3 |
1.81E-02 |
angiotensin ii mediated activation of jnk pathway via pyk2 dependent signaling |
|
|
|
|
39 |
24 |
3 |
1.81E-02 |
t cell receptor signaling pathway |
|
|
|
|
44 |
23 |
3 |
1.81E-02 |
links between pyk2 and map kinases |
|
|
|
|
39 |
24 |
3 |
2.02E-02 |
dicer pathway |
|
|
|
|
4 |
1 |
1 |
2.57E-02 |
AndrogenReceptor |
|
|
|
|
98 |
93 |
6 |
3.29E-02 |
Osteopontin-mediated events |
|
|
|
|
48 |
13 |
2 |
3.62E-02 |
TCR signaling in naïve CD8+ T cells |
|
|
|
|
188 |
72 |
5 |
3.66E-02 |
fas signaling pathway (cd95) |
|
|
|
|
24 |
14 |
2 |
4.16E-02 |
Ceramide signaling pathway |
|
|
|
|
90 |
55 |
5 |
4.48E-02 |